Lesions in small coronary vessels disease: Should drug-coated balloons replace drug-eluting stents as the treatment of choice?

EuroIntervention

Volumn 7, Issue SUPPL. K, 2011, Pages

  Byrne, Robert A ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Balloon angioplasty; Drug coated balloon; Drug eluting stent; Late loss; Restenosis; Small coronary vessels

Indexed keywords

RAPAMYCIN;

BALLOON; BARE METAL STENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; DRUG COATED BALLOON; DRUG ELUTING STENT; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; RISK FACTOR; SMALL CORONARY VESSEL DISEASE;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 80355130311     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7SKA8     Document Type: Review

References (32)

1. Byrne RA, Joner M, Massberg S, Kastrati A. Restenosis in bare metal and drug-eluting stents. In: Escaned J, Serruys PW, eds. Coronary Artery Stenosis: Imaging, structure and physiology. Tou- louse, France: PCR Publishing; 2010.
2. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol 2010;56:S1-42.
3. Byrne RA, Sarafoff N, Kastrati A, Schömig A. Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assess- ment. Drug Saf 2009;32:749-770.
4. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10. (Pubitemid 46986103)
5. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Bill- inger M, Meier B, Hess OM. Sirolimus-eluting stents associated with para- doxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231-236. (Pubitemid 40966848)
6. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kel- baek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Sey- farth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039.
7. Byrne RA, Iijima R, Mehilli J, Pinieck S, Bruskina O, Schömig A, Kastrati A. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. JACC Cardiovasc Interv 2009;2:291-299.
8. Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 2009;57:567-584.
9. Gray WA, Granada JF. Drug-coated balloons for the prevention of vascular restenosis. Circulation 2010;121:2672-2680.
10. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-1251. (Pubitemid 24284445)
11. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schömig A. Vessel size and long-term outcome after coronary stent placement. Circulation 1998;98:1875-1880. (Pubitemid 28509283)
12. Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, Schühlen H, Seyfarth M, Schmitt C, Blasini R, Neumann F-J, Schömig A. Reste- nosis after coronary placement of various stent types. Am J Cardiol 2001;87:34-39. (Pubitemid 32013081)
13. Kastrati A, Schuhlen H, Schömig A. Stenting for small coronary vessels: a contestable winner. J Am Coll Cardiol 2001;38:1604-1607. (Pubitemid 33065442)
14. Kastrati A, Schömig A, Dirschinger J, Mehilli J, Dotzer F, von Welser N, Neumann FJ. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intrac- oronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation 2000;102:2593-2598.
15. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Men- ichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Juni P. Outcomes associated with drug-elut- ing and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948.
16. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cut- lip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and effi- cacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
17. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Apple- gate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009;119:3198-3206.
18. Pache J, Dibra A, Mehilli J, Dirschinger J, Schömig A, Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J. 2005;26:1262-8. (Pubitemid 41435455)
19. Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, Hunziker P, Mueller C, Nietlispach F, Leibundgut G, Bader F, Kaiser C. Long- term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J 2009;30:16-24.
20. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner- La Rocca HP, Ricard I, Pfisterer M. Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries. N Engl J Med 2010;363:2310-9.
21. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, Angeloni G, Carosio G, Bonizzoni E, Colusso S, Repetto M, Merlini PA. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004;292:2727-2734. (Pubitemid 39628251)
22. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beck- erath N, Ulm K, Wessely R, Dirschinger J, Schömig A. Paclitaxel- eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
23. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schömig A. Siroli- mus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-171. (Pubitemid 40095867)
24. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schömig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006;27:260-266. (Pubitemid 43100018)
25. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124. (Pubitemid 44749319)
26. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengsten- berg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel- coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-2994.
27. Elezi S, Kastrati A, Hadamitzky M, Dirschinger J, Neumann FJ, Schömig A. Clinical and angiographic follow-up after balloon angi- oplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv 1999;48:151-156. (Pubitemid 29458311)
28. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel DI, Schroder S, Heinle H, Karsch KR. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976. (Pubitemid 30342882)
29. Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O, Pache J, Wessely R, Schömig A, Kastrati A. Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 2008;29:1975-1982.
30. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-174.
31. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 2010;96:1291-1296.
32. Agostoni P, Biondi-Zoccai GG, Gasparini GL, Anselmi M, Morando G, Turri M, Abbate A, McFadden EP, Vassanelli C, Zardini P, Colombo A, Serruys PW. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J 2005;26:881-889. (Pubitemid 40676568)